Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure

被引:10
|
作者
Chua, Alicia S. [1 ]
Glanz, Bonnie I. [1 ,2 ]
Guarino, Anthony J. [4 ]
Cook, Sandra L. [1 ]
Greeke, Emily E. [1 ]
Little, Grace E. [1 ]
Chitnis, Tanuja [1 ,2 ]
Healy, Brian C. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Partners Multiple Sclerosis Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Inst Hlth Profess, Ctr Intetprofess Studies & Innovat, Boston, MA 02114 USA
关键词
Multiple sclerosis; Social support; Depression; Fatigue; Quality of life; Patient-reported outcomes; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; HEALTH; QUESTIONNAIRE; DISABILITY; FATIGUE; INSTRUMENTS; CRITERIA; DISEASE; IMPACT;
D O I
10.1016/j.msard.2015.09.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several patient-reported outcome (PRO) measures are commonly used in multiple sclerosis (MS) research, but the relationship among items across measures is uncertain. We proposed to evaluate the associations between items from a standard battery of PRO measures used in MS research and to develop a brief, reliable and valid instrument measure by combining these items into a single measure. Subjects (N=537) enrolled in CLIMB complete a PRO battery that includes the Center for Epidemiologic Studies Depression Scale, Medical Outcomes Study Modified Social Support Survey, Modified Fatigue Impact Scale and Multiple Sclerosis Quality of Life-54. Subjects were randomly divided into two samples: calibration (n=269) and validation (n=268). In the calibration sample, an Exploratory Factor Analysis (EFA) was used to identify latent constructs within the battery. The model constructed based on the EFA was evaluated in the validation sample using Confirmatory Factor Analysis (CFA), and reliability and validity were assessed for the final measure. The EFA in the calibration sample revealed an eight factor solution, and a final model with one second-order factor along with the eight first-order factors provided the best fit. The model combined items from each of the four parent measures, showing important relationships among the parent measures. When the model was fit using the validation sample, the results confirmed the validity and reliability of the model. A brief PRO for MS (BPRO-MS) that combines MS-related psychosocial and quality of life domains can be used to assess overall functioning in mildly disabled MS patients. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 50 条
  • [41] Evaluating the impact of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
    Chu, Nathan Y. Y.
    Watson, Kaitlyn E. E.
    Al Hamarneh, Yazid N. N.
    Yushko, Lily
    Tsuyuki, Ross T. T.
    Smyth, Penelope
    BMC NEUROLOGY, 2023, 23 (01)
  • [42] Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
    He, Anna
    Spelman, Tim
    Manouchehrinia, Ali
    Ciccarelli, Olga
    Hillert, Jan
    McKay, Kyla
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (04): : 284 - 289
  • [43] Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis
    Sonder, Judith M.
    Balk, Lisanne J.
    van der Linden, Femke A. H.
    Bosma, Libertje V. A. E.
    Polman, Chris H.
    Uitdehaag, Bernard M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (14) : 1865 - 1871
  • [44] Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS)
    Donze, Cecile
    Mekies, Claude
    Paillot, Geraud
    Vermersch, Patrick
    Montagu, Guillaume
    Brechenmacher, Lucie
    Civet, Alexandre
    Pau, David
    Mouzawak, Catherine
    Cohen, Mikael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 92
  • [45] Patient-reported outcomes after surgery among patients with gynecological diseases in Japan
    Ueno, Taiki
    Watanabe, Kazushi
    Ikemoto, Tatsunori
    Matsushita, Hiroshi
    Kawanami, Katsuhisa
    Arai, Young-Chang
    Wakatsuki, Akihiko
    JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2021, 42 (01) : 22 - 28
  • [46] Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study
    Judith J Stephenson
    David M Kern
    Sonalee S Agarwal
    Ruth Zeidman
    Krithika Rajagopalan
    Siddhesh A Kamat
    John Foley
    Health and Quality of Life Outcomes, 10
  • [47] Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
    Oswald, Laura B.
    Gudenkauf, Lisa M.
    Li, Xiaoyin
    De Avila, Gabriel
    Peres, Lauren C.
    Kirtane, Kedar
    Gonzalez, Brian D.
    Hoogland, Aasha I.
    Nguyen, Oanh
    Rodriguez, Yvelise
    Baz, Rachid C.
    Shain, Kenneth H.
    Alsina, Melissa
    Locke, Frederick L.
    Freeman, Ciara
    Castaneda Puglianini, Omar
    Nishihori, Taiga
    Liu, Hien
    Blue, Brandon
    Grajales-Cruz, Ariel
    Jim, Heather S. L.
    Hansen, Doris K.
    CANCERS, 2023, 15 (19)
  • [48] Comparison of patient-reported outcome measures in multiple sclerosis
    Schaeffler, N.
    Schoenberg, P.
    Stephan, J.
    Stellmann, J. -P.
    Gold, S. M.
    Heesen, C.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (02): : 114 - 121
  • [49] Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60
    Hua, Le H.
    Harris, Haleigh
    Conway, Devon
    Thompson, Nicolas R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 252 - 256
  • [50] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
    Cindy J. Nowinski
    Deborah M. Miller
    David Cella
    Neurotherapeutics, 2017, 14 : 934 - 944